Minghui Pharmaceutical Secures $131 Million Pre-IPO Funding to Propel Global Expansion Minghui Pharmaceutical has announced the successful closing of $131 million in Pre-IPO financing to enhance their clinical programs and global reach.

Minghui Pharmaceutical Secures $131 Million Pre-IPO Funding to Propel Global Expansion #China #Shanghai #Minghui_Pharmaceutical #Qiming_Venture_Partners #OrbiMed

OrbiMed Secures $1.86 Billion for Healthcare Investment Fund V OrbiMed has successfully raised $1.86 billion for its Royalty and Credit Opportunities Fund V, targeting growth-oriented healthcare...

OrbiMed Secures $1.86 Billion for Healthcare Investment Fund V #USA #New_York #healthcare #Fund_V #OrbiMed

Mona Ashiya Elevates to General Partner at OrbiMed, Leads Investment Strategies OrbiMed has announced the promotion of Dr. Mona Ashiya to General Partner, enhancing its leadership in healthcare investments and biotechnology.

Mona Ashiya Elevates to General Partner at OrbiMed, Leads Investment Strategies #USA #New_York #biotechnology #OrbiMed #Mona_Ashiya